These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 15781835

  • 1. The effect of levetiracetam on essential tremor.
    Bushara KO, Malik T, Exconde RE.
    Neurology; 2005 Mar 22; 64(6):1078-80. PubMed ID: 15781835
    [Abstract] [Full Text] [Related]

  • 2. Pilot efficacy and tolerability: a randomized, placebo-controlled trial of levetiracetam for essential tremor.
    Handforth A, Martin FC.
    Mov Disord; 2004 Oct 22; 19(10):1215-21. PubMed ID: 15390011
    [Abstract] [Full Text] [Related]

  • 3. The effect of levetiracetam on tremor severity and functionality in patients with multiple sclerosis.
    Feys P, D'hooghe MB, Nagels G, Helsen WF.
    Mult Scler; 2009 Mar 22; 15(3):371-8. PubMed ID: 19168602
    [Abstract] [Full Text] [Related]

  • 4. Levetiracetam is not effective for essential tremor.
    Elble RJ, Lyons KE, Pahwa R.
    Clin Neuropharmacol; 2007 Mar 22; 30(6):350-6. PubMed ID: 18090460
    [Abstract] [Full Text] [Related]

  • 5. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S, De Smedt F, Toublanc N, Otoul C, Boulanger P, Riethuisen JM, Stockis A.
    Clin Ther; 2006 May 22; 28(5):734-44. PubMed ID: 16861095
    [Abstract] [Full Text] [Related]

  • 6. Levetiracetam in primary orthostatic tremor: a double-blind placebo-controlled crossover study.
    Hellriegel H, Raethjen J, Deuschl G, Volkmann J.
    Mov Disord; 2011 Nov 22; 26(13):2431-4. PubMed ID: 21953629
    [Abstract] [Full Text] [Related]

  • 7. Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study.
    Hulhoven R, Rosillon D, Bridson WE, Meeus MA, Salas E, Stockis A.
    Clin Ther; 2008 Feb 22; 30(2):260-70. PubMed ID: 18343264
    [Abstract] [Full Text] [Related]

  • 8. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J, Coetzee C, Jiménez F, Litovchenko T, Ramaratnam S, Zaslavaskiy L, Lu ZS, Sykes DM, Levetiracetam XR N01235 Study Group.
    Epilepsia; 2009 Mar 22; 50(3):406-14. PubMed ID: 19317886
    [Abstract] [Full Text] [Related]

  • 9. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial.
    Levisohn PM, Mintz M, Hunter SJ, Yang H, Jones J, N01103 Levetiracetam Study Group.
    Epilepsia; 2009 Nov 22; 50(11):2377-89. PubMed ID: 19702752
    [Abstract] [Full Text] [Related]

  • 10. A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor.
    Zesiewicz TA, Ward CL, Hauser RA, Sanchez-Ramos J, Staffetti JF, Sullivan KL.
    Mov Disord; 2007 Jan 15; 22(2):279-82. PubMed ID: 17149715
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Levetiracetam extended release and levetiracetam immediate release as adjunctive treatment for partial-onset seizures: an indirect comparison of treatment-emergent adverse events using meta-analytic techniques.
    Richy FF, Banerjee S, Brabant Y, Helmers S.
    Epilepsy Behav; 2009 Oct 15; 16(2):240-5. PubMed ID: 19699156
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy.
    Fattore C, Boniver C, Capovilla G, Cerminara C, Citterio A, Coppola G, Costa P, Darra F, Vecchi M, Perucca E.
    Epilepsia; 2011 Apr 15; 52(4):802-9. PubMed ID: 21320119
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures.
    Piña-Garza JE, Nordli DR, Rating D, Yang H, Schiemann-Delgado J, Duncan B, Levetiracetam N01009 Study Group.
    Epilepsia; 2009 May 15; 50(5):1141-9. PubMed ID: 19243423
    [Abstract] [Full Text] [Related]

  • 18. Levetiracetam in social phobia: a placebo controlled pilot study.
    Zhang W, Connor KM, Davidson JR.
    J Psychopharmacol; 2005 Sep 15; 19(5):551-3. PubMed ID: 16166192
    [Abstract] [Full Text] [Related]

  • 19. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
    Wu XY, Hong Z, Wu X, Wu LW, Wang XF, Zhou D, Zhao ZX, Lv CZ.
    Epilepsia; 2009 Mar 15; 50(3):398-405. PubMed ID: 18657175
    [Abstract] [Full Text] [Related]

  • 20. Levetiracetam and bleeding disorders.
    Boon P, Hulhoven R, Offner F.
    Acta Neurol Belg; 2007 Dec 15; 107(4):97-102. PubMed ID: 18416281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.